Zevra Therapeutics, Inc. ZVRA Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s net debt?
- Zevra Therapeutics, Inc. (ZVRA) reported net debt of -$94.45M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s net debt changed year-over-year?
- Zevra Therapeutics, Inc.'s net debt decreased by 485.5% year-over-year, from $24.5M to -$94.45M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s net debt?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s net debt has grown at a -17.6% compound annual growth rate (CAGR), from -$2.11M to $800K.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.